Jon J. van Rood - Publications

Affiliations: 
Leiden University, Leiden, Netherlands 
Area:
Immunohematology
Website:
http://knaw.nl/Pages/DEF/26/614.bGFuZz1OTA.html

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Pingel J, Wang T, Hagenlocher Y, Hernández-Frederick CJ, Nagler A, Haagenson MD, Fleischhauer K, Hsu KC, Verneris MR, Lee SJ, Mohty M, Polge E, Spellman SR, Schmidt AH, van Rood JJ. The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR. Bone Marrow Transplantation. PMID 30279575 DOI: 10.1038/S41409-018-0345-8  0.315
2016 Velardi A, Ruggeri L, Ziagkos D, van Biezen A, Merluzzi M, Bondanza A, Bootsman N, Massei MS, Amico L, Piccinelli S, Noviello M, Ciceri F, Klingebiel T, Koc Y, Veelken H, ... ... van Rood JJ, et al. Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT Blood. 128: 3472-3472. DOI: 10.1182/BLOOD.V128.22.3472.3472  0.3
2015 Kosmoliaptsis V, Jöris MM, Mallon DH, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Bradley JA, Oudshoorn M, van Rood JJ, Taylor CJ, Claas FH. Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT. Bone Marrow Transplantation. 50: 540-4. PMID 25621806 DOI: 10.1038/bmt.2014.305  0.347
2015 Pingel J, Hernandez Frederick CJ, Wang T, Polge E, Haagenson MD, Lee SJ, Mohty M, Nagler A, Spellman SR, Schmidt AH, van Rood JJ. Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR Blood. 126: 3226-3226. DOI: 10.1182/Blood.V126.23.3226.3226  0.336
2014 Van der Zanden HG, Van Rood JJ, Oudshoorn M, Bakker JN, Melis A, Brand A, Scaradavou A, Rubinstein P. Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1791-5. PMID 25042738 DOI: 10.1016/j.bbmt.2014.07.011  0.303
2013 Jöris MM, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Haasnoot GW, van der Zanden HG, van Walraven SM, van Rood JJ, Claas FH, Oudshoorn M. The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT. Bone Marrow Transplantation. 48: 483-90. PMID 23064039 DOI: 10.1038/bmt.2012.189  0.331
2012 Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, ... ... van Rood JJ, et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1890-6. PMID 22814031 DOI: 10.1016/j.bbmt.2012.07.010  0.318
2012 van Rood JJ, Scaradavou A, Stevens CE. Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation. Proceedings of the National Academy of Sciences of the United States of America. 109: 2509-14. PMID 22232664 DOI: 10.1073/pnas.1119541109  0.339
2011 van Rood JJ, Scaradavou A, Stevens C. Indirect Evidence That Maternal Microchimerism in Cord Blood (CB) Mediates a Graft Versus Leukemia Effect After Transplantation to Unrelated CB Graft Recipients Blood. 118: 829-829. DOI: 10.1182/blood.V118.21.829.829  0.34
2009 van Rood JJ, Stevens CE, Smits J, Carrier C, Carpenter C, Scaradavou A. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proceedings of the National Academy of Sciences of the United States of America. 106: 19952-7. PMID 19901324 DOI: 10.1073/pnas.0910310106  0.35
2007 Christiansen F, Witt C, Bardy P, Dunckley H, Holdsworth R, Nicholson I, Knowles S, Varney M, Kanaan C, Diviney M, Tait B, Fischer G, Mayr W, Gervais T, Ferrant A, ... ... Van Rood J, et al. 14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation Tissue Antigens. 69: 17-24. PMID 17445157 DOI: 10.1111/j.1399-0039.2006.759_1.x  0.301
2006 Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, et al. The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry Biology of Blood and Marrow Transplantation. 12: 876-884. PMID 16864058 DOI: 10.1016/J.Bbmt.2006.05.007  0.302
2006 Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 828-36. PMID 16864053 DOI: 10.1016/J.Bbmt.2006.04.008  0.335
2005 van Rood JJ, Roelen DL, Claas FH. The effect of noninherited maternal antigens in allogeneic transplantation. Seminars in Hematology. 42: 104-11. PMID 15846576 DOI: 10.1053/j.seminhematol.2005.01.008  0.306
1999 van Rood JJ, van Leeuwen A. Soluble HLA antigens: how it all started. Human Immunology. 60: 412-3. PMID 10447399 DOI: 10.1016/S0198-8859(99)00009-9  0.324
1998 van Rood JJ, Oudshoorn M. An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor? Bone Marrow Transplantation. 22: S83. PMID 9715900  0.352
1997 Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, ... ... van Rood JJ, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1767-77. PMID 9164184 DOI: 10.1200/Jco.1997.15.5.1767  0.335
1996 Zantvoort FA, D'Amaro J, Persijn GG, Cohen B, Schreuder GM, Van Rood JJ, Thorogood J. The impact of HLA-A matching on long-term survival of renal allografts. Transplantation. 61: 841-4. PMID 8607195 DOI: 10.1097/00007890-199603150-00030  0.337
1996 Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. The New England Journal of Medicine. 334: 281-5. PMID 8532022 DOI: 10.1056/NEJM199602013340501  0.32
1995 Roelen DL, van Beelen E, van Bree SP, van Rood JJ, Völker-Dieben HJ, Claas FH. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation. 59: 1039-42. PMID 7709440  0.327
1994 Roelen DL, van Bree SP, van Beelen E, Schanz U, van Rood JJ, Claas FH. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens. Transplantation. 57: 446-50. PMID 8108881  0.303
1994 Doxiadis I, Maruya E, Thorogood J, Takemoto S, Schreuder G, Persijn G, Terasaki P, van Rood J. Permissible HLA mismatches for kidney transplants Human Immunology. 39: 130. DOI: 10.1016/0198-8859(94)90148-1  0.31
1993 van Rood JJ. HLA and I. Annual Review of Immunology. 11: 1-28. PMID 8476557 DOI: 10.1146/annurev.iy.11.040193.000245  0.325
1993 Marijt EA, Veenhof WF, Goulmy E, Kluck PM, Brand A, Willemze R, van Rood JJ, Falkenburg JH. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Human Immunology. 37: 221-8. PMID 8300407 DOI: 10.1016/0198-8859(93)90505-U  0.331
1993 Thorogood J, Doxiadis II, Schreuder GM, Persijn GG, van Rood JJ. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors. Transplantation Proceedings. 25: 3051-2. PMID 8266449  0.311
1993 van Rood JJ, Claas FH, Doxiadis II, Schreuder GM, Persijn GG. The role of HLA typing in clinical kidney transplants: 30 years later HLA matching is prime importance in bone marrow transplantation. Clinical Transplants. 434-5. PMID 7918177  0.316
1993 Roelen D, van Bree S, Schanz U, van Beelen E, van Rood J, Claas F. Quantitative and qualitative differences between CTLP against HLA-A antigens and CTLP against HLA-B antigens Human Immunology. 36: 64. DOI: 10.1016/0198-8859(93)90094-H  0.329
1992 van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ, van Rood JJ, Goulmy E. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics. 35: 161-5. PMID 1537607 DOI: 10.1007/Bf00185109  0.345
1992 Thorogood J, Schreuder GM, Persijn GG, van Rood JJ. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. Transplantation Proceedings. 24: 2485-7. PMID 1465839  0.314
1991 Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T, McGlave PB, Rimm AA, Ringden O, van Rood JJ, Sondel PM, et al. Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T cell depletion Bone Marrow Transplantation. 7: 443-452. PMID 1873591  0.311
1991 De Bueger M, Bakker A, Van Rood JJ, Goulmy E. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells. European Journal of Immunology. 21: 2839-44. PMID 1682155 DOI: 10.1002/Eji.1830211127  0.352
1990 van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplantation. 5: 365-72. PMID 2142441  0.315
1989 Claas FH, van Leeuwen A, van Rood JJ. Hyperimmunized patients do not need to wait for an HLA identical donor. Tissue Antigens. 34: 23-9. PMID 2683206  0.316
1989 Lagaaij EL, Hennemann IP, Ruigrok M, de Haan MW, Persijn GG, Termijtelen A, Hendricks GF, Weimar W, Claas FH, van Rood JJ. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. The New England Journal of Medicine. 321: 701-5. PMID 2671729 DOI: 10.1056/NEJM198909143211101  0.335
1989 Claas FH, de Waal LP, Beelen J, Reekers P, Berg-Loonen PV, de Gast E, D'Amaro J, Persijn GG, Zantvoort F, van Rood JJ. Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches. Clinical Transplants. 185-90. PMID 2487564  0.316
1988 Persijn GG, D'Amaro J, De Lange P, Schreuder GM, Thorogood J, Zantvoort F, Van Rood JJ. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988. Clinical Transplants. 237-48. PMID 3154476  0.332
1987 Nagesser SK, Bosch ML, van Rood JJ, Termijtelen A. Matching for supertypic DR epitopes does not reduce mixed lymphocyte culture reactivity. Scandinavian Journal of Immunology. 26: 455-8. PMID 2446382 DOI: 10.1111/j.1365-3083.1987.tb02278.x  0.301
1986 Persijn GG, Schreuder GM, Hendriks GF, Cohen B, D'Amaro J, van Rood JJ. Cyclosporin, HLA matching, and transfusions in kidney transplants. Lancet. 2: 915-6. PMID 2876342  0.312
1986 Claas FH, van Ree JM, Verhoeven WM, van der Poel JJ, Verduyn W, de Wied D, van Rood JJ. The interaction between gamma-type endorphins and HLA class I antigens. Human Immunology. 15: 347-56. PMID 2422143 DOI: 10.1016/0198-8859(86)90011-X  0.324
1985 Goulmy E, Blokland E, Persijn G, Paul LC, Wilmink J, van Rood JJ. HLA regulates postrenal transplant CML nonreactivity. Journal of Immunology (Baltimore, Md. : 1950). 135: 3082-6. PMID 3900203  0.311
1985 Falkenburg JH, Fibbe WE, Goselink HM, Van Rood JJ, Jansen J. Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens. The Journal of Experimental Medicine. 162: 1359-69. PMID 3862746  0.3
1983 Hendriks GF, Schreuder GM, Claas FH, D'Amaro J, Persijn GG, Cohen B, van Rood JJ. HLA-DRw6 and renal allograft rejection. British Medical Journal (Clinical Research Ed.). 286: 85-7. PMID 6401505 DOI: 10.1136/Bmj.286.6359.85  0.309
1983 Vasilov RG, Hahn A, Mölders H, van Rood JJ, Breuning M, Ploegh HL. Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens. Immunogenetics. 17: 333-56. PMID 6187677 DOI: 10.1007/BF00372454  0.427
1983 Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature. 302: 159-61. PMID 6186923  0.31
1983 Hendriks GF, D'Amaro J, Persijn GG, Schreuder GM, Lansbergen Q, Cohen B, van Rood JJ. Excellent outcome after transplantation of renal allografts from HLA-DRw6-positive donors even in HLA-DR mismatches. Lancet. 2: 187-9. PMID 6135028  0.317
1982 Persijn GG, Cohen B, Lansbergen Q, D'Amaro J, Selwood N, Wing A, van Rood JJ. Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. The New England Journal of Medicine. 307: 905-8. PMID 7050716 DOI: 10.1056/Nejm198210073071501  0.341
1978 van Rood JJ. [Immunologic HLA-typing. A tool for selection of recipients in transplantation and for detection of disposition to certain diseases (author's transl)]. Klinische Wochenschrift. 55: 1209-15. PMID 338972 DOI: 10.1007/BF01682286  0.343
1977 Berrill WT, van Rood JJ. HLA-DW6 and avian hypersensitivity. Lancet (London, England). 2: 248-9. PMID 69855 DOI: 10.1016/S0140-6736(77)92864-1  0.313
1971 Balner H, Van Rood JJ. Transplantation antigens in rhesus monkeys. Nature. 232: 121. PMID 4997051 DOI: 10.1038/232121A0  0.304
Show low-probability matches.